Articles

The CDMO will run the active pharmaceutical ingredient pilot plant in Sandwich, UK, along with development laboratories. 

Asymchem Takes Ownership of Former Pfizer Manufacturing Facilities

The deal features felzartamab, an investigational anti-CD38 monoclonal antibody, whose clinical outcomes have shown potential to tackle various immune-mediated diseases.

Biogen Agrees to Acquire HI-BIO for $1.15 Billion

The document reiterates the company’s commitment to ESG principles, including carbon neutrality by 2030.

Tower Cold Chain Submits Its First-Ever Sustainability Report

The decision comes after success during formulation testing with convincing stability data.

TFF Pharmaceuticals, Cleveland Clinic to Move Their Influenza Vaccine Candidates into Preclinical Testing

The agreement is expected to focus on cell manufacturing processes, with potential for sharing tech with academia, startups.

Astellas, YASKAWA Sign Cell Therapy MoU Powered by Robotics Technology

Videos

In an interview with Pharma Commerce Associate Editor Don Tracy, Ron Lanton, Partner, Lanton Law offers his thoughts on the recent Federal Trade Commission (FTC) repeal of non-compete agreements, and how it could effect the pharma industry. 

Effects of the Federal Trade Commission's Repeal of Non-Compete Agreements on the Pharma Industry

The facility, company says, will be its first that covers end-to-end ADC production.

AstraZeneca to Build $1.5 Billion Antibody Drug Conjugates Manufacturing Plant in Singapore

The company increases its selection of atopic dermatitis treatments in the process.

Johnson & Johnson Purchases Proteologix for $850 Million

Leaders in the space discuss aspects of experimental drug support and more at this year’s US Pharma and Biotech Summit.  

Financially Supporting Pharma Innovation

Podcasts

Chip Davis recaps the organization’s Distribution Management Conference and addresses distributors’ preparedness for DSCSA implementation. 

News